BNKK

BNKK is not an operating company you can underwrite; it is a micro-cap shell whose equity value is now a leveraged bet on a volatile memecoin. Per the MD&A, this is the former Safety Shot, Inc. (once ticker SHOT) — an eight-employee consumer-packaged-goods outfit selling a 12-oz 'anti-alcohol' dietary beverage plus odds-and-ends suncare, hair-loss and 'vitiligo' products — that renamed to Bonk, Inc. and bolted on a 'BONK Holdings and Treasury Strategy.' The entire first block of Item 1A risk factors is about the BONK token being 'a highly volatile asset,' citing FTX, Celsius, Terra USD and sanctions/terror-financing perception risk. That means the $41.0M asset base and $35.0M of equity are dominated by a crypto holding that can reprice violently, so the tidy-looking 0.17x liabilities/equity ratio is meaningless as a measure of safety.

The operating business does not work. FY2025 revenue was just $2.12M, and while that is +201.6% YoY, the four-year history is erratic and tiny ($2.88M → $121K → $203K → $702K → $2.12M) — there is no durable growth curve here. Against that revenue the company lost $68.2M (net margin -3,220%) and burned $25.3M in operating cash. Accumulated deficit is -$183M and ROE is -194.8%. R&D was cut to $24.2K, so there is no product engine funding the future. The 89.5% collapse in share count and the -$17.02 diluted EPS point to a reverse split masking prior dilution — classic distressed micro-cap mechanics.